Nanostructured Degradable Polymer for Drug Delivery. The success of synthesising nanostructured degradable polymers will position Australia at the world forefront in the field of nanotechnology, bioengineering and healthcare sectors in both fundamental and applied research. This multi-disciplinary research has the potential to generate patentable technologies with economic benefits to Australia. The project also involves fundamental research into surface chemistry, nanostructure, polymer science ....Nanostructured Degradable Polymer for Drug Delivery. The success of synthesising nanostructured degradable polymers will position Australia at the world forefront in the field of nanotechnology, bioengineering and healthcare sectors in both fundamental and applied research. This multi-disciplinary research has the potential to generate patentable technologies with economic benefits to Australia. The project also involves fundamental research into surface chemistry, nanostructure, polymer sciences and will be a meaningful contribution to the advancement of scientific knowledge in Australia. All these will enhance the international competitive profile of Australia in the field of nanotechnology for drug delivery.Read moreRead less
Functional Nano-cement Scaffolds For The Treatment Of Osteoporotic Bone Defects
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
Osteoporosis affects 1.2 million Australians and will cost $33.6 billion by 2022. This study aims to develop a novel nano-cement platform for custom-designed bone repair in osteoporosis, by using purpose-designed nanomaterials and advanced 3D printing technique. The research findings will lead to the development of a new bone repair strategy, expand knowledge on both biomaterials engineering and osteoporosis treatment, and improve the quality of life of Australians.
Designed Delivery - Novel Hydrogels for Drug Delivery from Precisely-Structured Networks. This project will lead to the development of new biodegradable biomaterials ideally suited to many applications in drug delivery and tissue engineering. The understanding of their properties will be built on comprehensive models for diffusion of molecules through the material. The availability of these new biomaterials will facilitate future developments in drug delivery, and will ultimately lead to improve ....Designed Delivery - Novel Hydrogels for Drug Delivery from Precisely-Structured Networks. This project will lead to the development of new biodegradable biomaterials ideally suited to many applications in drug delivery and tissue engineering. The understanding of their properties will be built on comprehensive models for diffusion of molecules through the material. The availability of these new biomaterials will facilitate future developments in drug delivery, and will ultimately lead to improved medical outcomes in many areas such as tissue and bone regeneration. The materials designed in this project will help position the Australian biotechnology and pharmaceutical industries to take advantage of the more than $100B USD market (US alone; growth ~ 10% p.a.) in drug delivery.Read moreRead less
A Fibroin-based Prosthetic Bruch's Membrane For The Treatment Of Age-related Macular Degeneration
Funder
National Health and Medical Research Council
Funding Amount
$538,080.00
Summary
Our aim is to develop a new therapy for the treatment of patients with age-related macular degeneration (AMD), a leading cause of blindness in our ageing population. The novelty of our therapy resides in using a protein derived from silk fibers (fibroin), to rebuild a healthy barrier between the outermost layer of the retina and adjacent blood vessels. We expect that the findings from this study will eventually lead to better outcomes for patients with AMD.
Cultivated Corneal Endothelial Cell Implants For Restoring Vision
Funder
National Health and Medical Research Council
Funding Amount
$886,032.00
Summary
Thousands of Australians each year receive a corneal tissue transplant from the eyes of a deceased organ donor. In the majority of cases these transplants are performed to restore structure and function to the most posterior layer of the cornea – the corneal endothelium. The reliance upon donor tissue, however, presents significant logistical and safety issues. Our goal is therefore to develop improved strategies for treating diseases of the corneal endothelium using cultivated tissue implants.
A Novel Mesenchymal Stromal Cell And Biomaterial For Corneal Reconstruction
Funder
National Health and Medical Research Council
Funding Amount
$508,611.00
Summary
Our research group has identified a new cell type (L-MSC) with the potential to treat a variety of eye diseases. We have also developed a novel material from a protein found in silk, that has potential as a vehicle for delivering healthy cells into diseased eyes. The present project will build upon these promising results by evaluating the properties of L-MSC necessary for clinical use and by testing the feasibility of our new cell delivery system.
Bilayered and growth factor-loaded composite scaffolds for the guided bi-differentiation of bone marrow stem cells. The project will regenerate bone-cartilage (osteochondral) tissues using scaffolds, growth factors, and stem cells in order to repair osteochondral defects. The project will improve the quality of life for ~1.4 million Australians suffering from joint pain and disability due to damage or disease of cartilage and subchondral bone. The project will promote Australia research strength ....Bilayered and growth factor-loaded composite scaffolds for the guided bi-differentiation of bone marrow stem cells. The project will regenerate bone-cartilage (osteochondral) tissues using scaffolds, growth factors, and stem cells in order to repair osteochondral defects. The project will improve the quality of life for ~1.4 million Australians suffering from joint pain and disability due to damage or disease of cartilage and subchondral bone. The project will promote Australia research strength in biomaterials, tissue engineering, and drug delivery. The project will also create research opportunities for PhD students, who will be equipped with interdisciplinary skills.Read moreRead less
Meso- and Macro-porous Bioactive Glasses for Bone-repairing. This project aims to use self-assembly and pore engineering at different length scales to fabricate novel bioactive glasses of highly ordered mesoporous structure. By precisely controlling the composition, size and volume of both mesopores and macropores, bioactive glasses with improved bone forming activities will be obtained. The successful synthesis of such bioactive glasses is expected to lead to the fundamental understanding of st ....Meso- and Macro-porous Bioactive Glasses for Bone-repairing. This project aims to use self-assembly and pore engineering at different length scales to fabricate novel bioactive glasses of highly ordered mesoporous structure. By precisely controlling the composition, size and volume of both mesopores and macropores, bioactive glasses with improved bone forming activities will be obtained. The successful synthesis of such bioactive glasses is expected to lead to the fundamental understanding of structure-bioactivity relationship, and new materials effective for tissue engineering. This will also open up new opportunities for other applications such as drug delivery, implanting.Read moreRead less
Convergence of biomaterials and immunology: a technology platform for delayed burst release of vaccines. A large challenge in vaccination, particularly in wildlife such as for the growing problem of Chlamydia in koalas, is to provide the necessary booster shots. This project will develop implants that will be inserted under the skin at the time of the first shot, and will spontaneously burst later to release the booster shot to provide protection.
Bioactive Polymers for Wound Healing Applications. VitroGroR is a growth factor complex which enhances cell growth and migration, and hence has great potential for treating wounds. Tissue Therapies, which holds the rights to commercialization of VitroGroR, is seeking to develop methods of delivering VitroGroR in its active form to the wound environment. Two solutions to this problem will be developed in this project; a bioactive bandage containing a novel combination of microspheres and a hydrog ....Bioactive Polymers for Wound Healing Applications. VitroGroR is a growth factor complex which enhances cell growth and migration, and hence has great potential for treating wounds. Tissue Therapies, which holds the rights to commercialization of VitroGroR, is seeking to develop methods of delivering VitroGroR in its active form to the wound environment. Two solutions to this problem will be developed in this project; a bioactive bandage containing a novel combination of microspheres and a hydrogel matrix, and secondly an in-situ polymerisable matrix for treatment of deep wounds. The growth factor complex will be protected from aggressive proteases through encapsulation within microspheres, and the use of MMP-inhibiting comonomers.Read moreRead less